Efficacy and Safety of Combined PD-1 Inhibitor with Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis [Corrigendum]
Year: 2025
Type: erratum
Abstract: Chen K, Huang X, Chen J, Zhang S. Onco Targets Ther. 2025;18:283–296. The authors have advised that Table 1 on page 287 is incorrect. The Characteristics “Sintilimab” and “Toripalimab” listed in the PD-1 inhibitors section are interchanged. The correct Table 1 is as follows. Table 1 Baseline characteristics of patients The authors apologize for the error.
Authors: Chen,Kebin, Huang,Xiaopeng, Chen,Jiawei, Zhang,Shuai
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7000108107
Cites:
Cited by:
Related to: